Massachusetts Dermatologist Establishes Covid-19 Vaccination Site for School Nurses

American Academy of Dermatology recognizes Dr. Louis Kuchnir as National “Patient Care Hero”
American Academy of Dermatology

Newswise — ROSEMONT, Ill. (June 2, 2021) — Local board-certified dermatologist Louis Kuchnir, MD, FAAD, was honored as an American Academy of Dermatology Patient Care Hero for establishing a COVID-19 vaccination site in Marlborough, Mass. for school nurses at a time early in the vaccine rollout when vaccines were in short supply.

After receiving more COVID-19 vaccinations than his dermatology staff needed, Dr. Kuchnir acted quickly to ensure the vaccines were utilized by public health professionals, which was a state mandate at that time. Coordinating with local superintendents, Dr. Kuchnir organized a vaccination site at his dermatology office to make the vaccine available for school nurses who were eligible in Phase 1A of the state’s distribution plan.

“When I realized I had a surplus of COVID-19 vaccines I knew I couldn’t let them go to waste,” said Dr. Kuchnir. “It was rewarding to contribute to school safety and show how dermatologists in a small community can be a resource for others.”

The clinic remained open two evenings in early January to vaccinate school nurses from eight local school districts including Grafton, Marlborough, and Waltham, who returned weeks later for their second doses.

“School nurses found it difficult to receive the COVID-19 vaccines needed to do our critical work safely,” said Julia McCoskery, RN, a nurse for Westborough Public Schools who received her vaccination at Dr. Kuchnir’s vaccination site. “I am grateful to Dr. Kuchnir for donating his time, clinic, and extra vaccines to ensure school nurses can continue keeping our communities healthy.”

The AAD created the Patient Care Heroes program to recognize physicians who transform patients’ lives by utilizing their expertise and collaborating with other physicians.

“Dermatologists care deeply about the health and well-being of their communities,” said board-certified dermatologist Ken Tomecki, MD, FAAD, president of the AAD. “Our profession has risen to the challenges of this pandemic in so many ways, including efforts like this to protect all who are involved in caring for our communities.”

To learn more about the work of Dr. Kuchnir, visit www.aad.org/skinserious/stories-derick-kuchnir.

 

###

 

About SkinSerious

SkinSerious is a campaign by the American Academy of Dermatology that highlights dermatologists’ role as partners in the health care system, providing expert care for serious conditions. To learn more, visit SkinSerious.org

 

About the AAD

Headquartered in Rosemont, Ill., the American Academy of Dermatology, founded in 1938, is the largest, most influential, and most representative of all dermatologic associations. With a membership of more than 20,000 physicians worldwide, the AAD is committed to: advancing the diagnosis and medical, surgical and cosmetic treatment of the skin, hair and nails; advocating high standards in clinical practice, education, and research in dermatology; and supporting and enhancing patient care for a lifetime of healthier skin, hair and nails. For more information, contact the AAD at (888) 462-DERM (3376) or aad.org. Follow the AAD on Facebook (American Academy of Dermatology), Twitter (@AADskin), Instagram (@AADskin1), or YouTube (AcademyofDermatology).

 



Filters close

Showing results

110 of 6084
Newswise: Public
Released: 28-Jul-2021 2:45 PM EDT
Highly Potent, Stable Nanobodies Stop SARS-CoV-2
Max Planck Society (Max-Planck-Gesellschaft)

Göttingen researchers have developed mini-antibodies that efficiently block the coronavirus SARS-CoV-2 and its dangerous new variants.

Newswise: Public
Released: 28-Jul-2021 2:20 PM EDT
Psychological Consequences of COVID-19 in Health Care
University of Bonn

Physicians, nursing staff, medical technical assistants, and pastoral workers in hospitals: they have all been placed under severe strain by the Covid-19 pandemic.

Newswise: Public
Released: 28-Jul-2021 2:10 PM EDT
Why Lockdown in Africa Does Not Work as a First COVID-19 Pandemic Response
University of Johannesburg

In an African pandemic it is more productive to consider lockdowns, after using other non-medical measures first, Especially in countries with high levels of poverty and corruption, says Prof Nicholas Ngepah, a Professor of Economics at the University of Johannesburg in South Africa.

Newswise:Video Embedded how-to-talk-with-people-who-are-not-vaccinated-against-covid-19
VIDEO
Released: 28-Jul-2021 1:40 PM EDT
How to Talk With People Who Are Not Vaccinated Against COVID-19
Cedars-Sinai

Even though she has asthma, putting her at higher risk for severe complications from COVID-19, Angela Reeves-Flores, 33, waited until a week ago to get vaccinated.

Newswise: Indian Women’s Nutrition Suffered During COVID-19 Lockdown
Released: 28-Jul-2021 12:50 PM EDT
Indian Women’s Nutrition Suffered During COVID-19 Lockdown
Cornell University

A new study from Cornell University finds the nationwide lockdown India imposed last year in response to COVID-19 caused disruptions that negatively impacted women’s nutrition.

Released: 28-Jul-2021 12:00 PM EDT
MD Anderson Research Highlights for July 28, 2021
University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights provides a glimpse into recently published studies in basic, translational and clinical cancer research from MD Anderson experts. Current advances include a newly discovered protein that controls B cell survival, understanding epigenetic changes in malignant peripheral nerve sheath tumors (MPNSTs) and melanoma, identifying a protein that protect genome stability, developing novel cell therapies for COVID-19, a new option for treating neuropathic pain, exosome delivery of CRISPR/Cas9 to pancreatic cancer, discovering how cancer cells tolerate aneuploidy and the role of health disparities in long-term survival of adolescent and young adult patients with Hodgkin lymphoma.

Released: 28-Jul-2021 11:30 AM EDT
Study Reveals Characteristics of SARS-CoV-2 Spike Protein
University of Kentucky

A new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry provides foundational information about SARS-CoV-2’s spike protein.

access_time Embargo lifts in 2 days
Embargo will expire: 4-Aug-2021 9:00 AM EDT Released to reporters: 28-Jul-2021 11:15 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 4-Aug-2021 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: UIC Awarded $6 Million to Develop Potential COVID-19 Treatment
Released: 28-Jul-2021 10:15 AM EDT
UIC Awarded $6 Million to Develop Potential COVID-19 Treatment
University of Illinois Chicago

Researchers at the University of Illinois Chicago are developing a potential treatment for COVID-19, thanks to a $6 million technology and therapeutic development award from the U.S. Department of Defense supporting pre-clinical animal studies.

Newswise: Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Released: 28-Jul-2021 8:55 AM EDT
Don’t Let the Raging Virus Put Life in Jeopardy. Chula Recommends How to Build an Immunity for Your Heart Against Stress and Depression
Chulalongkorn University

Cumulative stress, denial, and chronic depression are the byproducts of the COVID-19 pandemic. The Center for Psychological Wellness, Chulalongkorn University recommends ways to cope by harnessing positive energy from our heart.


Showing results

110 of 6084

close
2.49828